Global IVD Products and Test Market - Strategic Volume and Pricing Analysis 2012-2016

Global IVD Products and Test Market - Strategic Volume and Pricing Analysis 2012-2016

Category : Healthcare

TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global In Vitro Diagnostics (IVD) Products and Test market to grow at a CAGR of 4.33 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant growth of the IVD market in emerging countries. The market has also been witnessing a significant increase in the number of acquisitions of small and medium companies. However, the emergence of counterfeit or duplicate IVD products could pose a challenge to the growth of this market. 
TechNavio's report, the Global IVD Products and Test Market - Strategic Volume and Pricing Analysis 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, F. Hoffmann-La Roche Ltd., and Siemens Healthcare.
The other vendors mentioned in the report are 23andMe Inc., A. Menarini Diagnostics S.r.l., Affymetrix Inc., Agilent Technologies Inc., Alere Inc., ARKRAY Inc., Arrayit Diagnostics Inc, Astra Biotech GmbH, Axis-Shield plc, Beckman Coulter Inc., BG Medicine Inc., Bio-Rad Laboratories Inc., Bruker BioSciences Corp., Caliper Life Sciences Inc., Celera Diagnostics LLC, Cepheid Inc., China Medical Technologies Inc., Dako A/S, Danaher Corp., DiaSorin S.p.A., Eiken Chemical Co. Ltd., ELITech SA, Enzo Biochem Inc., Epigenomics AG, Fujirebio Diagnostics Inc., GE Healthcare, Grifols SA, Horiba Ltd., Idaho Technology Inc., Illumina Inc., Innogenetics NV, Instrumentation Laboratory Company, International Technidyne Corp., Intrinsic Bioprobes Inc., IRIS International Inc., Life Technologies Corp., Linkage Biosciences Inc., Luminex Corp., Magellan Biosciences Inc., Millipore Corp., Mitsubishi Chemical Medience Corp., Nanosphere Inc., Nanosphere Inc., Nova Biomedical Corp., Novartis AG, OPTI Medical Systems Inc., OptiGene Ltd., Ortho-Clinical Diagnostics Inc., PerkinElmer Inc., Phadia AB, Polymedco Inc., QIAGEN N.V., Quidel Corp., Radient Pharmaceuticals Corp., Radiometer A/S, Randox Laboratories Ltd., Seegene Inc., SensiGen LLC,  Sequenom Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Spartan Bioscience Inc., Sysmex Corp., TessArae LLC, Thermo Fisher Scientific Inc., Tosoh Corp., Transasia Bio-Medicals Ltd., Transgenomic Inc., TrimGen Corp., Trinity Biotech plc, TrovaGene Inc., Ventana Medical Systems Inc., Veridex LLC, Vermillion Inc., Wako Pure Chemical Industries Ltd., and Werfen Life Group SA.
Key questions answered in this report:
What will the market size be in 2015 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

 

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology


Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Market Landscape

06.1 Global IVD Products and Test Market

Market Size

Market Forecast

06.2 Five Forces Analysis

07. Market Growth Drivers

08. Drivers and their Impact

09. Market Challenges

10. Impact of Drivers and Challenges

11. Market Trends

12. Market Segmentation

13. Volume Analysis


13.1 POC Test

OTC Tests

Professional Tests

Volume Analysis of POC Tests

Volume Trends

13.2 Core Laboratory Test

Key Segmentation

Clinical Chemistry

Immunoassay

Volume Analysis of Core Laboratory Tests

Volume Trends

13.3 Molecular Test

Key Segmentation

Infectious Diseases

Oncology

Inherited Diseases

Other Tests

Volume Analysis of Molecular Test

Volume Trends

13.4 Haematology Test

Volume Analysis by Test Type

Volume Trends

13.5 Coagulation Test

Key Segmentation

International Normalized Ratio

Activated Thromboplastin Time

Volume Analysis by Test Type

Volume Trends

13.6 Microbiology Test

Key Segmentation

Automated Panels and Reagents

Blood Culture

Chromogenic Media

Manual Panels and Reagents

Volume Analysis by Test Type

Volume Trends

13.7 Blood Banking Test

Volume Analysis by Test Type

Volume Trends

13.8 Histology/Cytology Test

Key Segmentation

Pap Stains

Non-pap Stains

Image Cytometry

Flow Cytometry

IHC and ISH

Circulating Tumour Cells

Volume Analysis by Test Type

Volume Trends

14. Pricing Analysis

14.1 POC Test

Market Overview

Major Products

Pricing Trends

14.2 Core Laboratory Test

Market Overview

Major Products

Pricing Trends

14.3 Molecular Test

Market Overview

Major Products

Pricing Trends

14.4 Haematology Test

Market Overview

Major Products

Pricing Trends

14.5 Coagulation Test

Market Overview

Major Products

Pricing Trends

14.6 Microbiology Test

Market Overview

Major Products

Pricing Trends

14.7 Blood Banking Test

Market Overview

Major Products

Pricing Trends

14.8 Histology/Cytology Test

Market Overview

Major Products

Pricing Trends

15. Geographical Segmentation

16. Key Leading Countries

US

Germany

Japan

17. Vendor Landscape by Sales

18. Vendor Landscape by Volume

19. Buying Criteria

20. Key Vendor Analysis


20.1 Abbott Laboratories

Business Overview

Key Information

SWOT Analysis

20.2 Becton Dickinson and Company

Business Overview

Key Information

SWOT Analysis

20.3 bioMerieux SA

Business Overview

Key Information

SWOT Analysis

20.4 F. Hoffmann-La Roche Ltd.

Business Overview

Key Information

SWOT Analysis

20.5 Siemens Healthcare

Business Overview

Key Information

SWOT Analysis

21. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global IVD Products and Test Market by Sales 2012–2016 (US$ million)

Exhibit 3: Global IVD Products and Test Market by Volume 2012–2016 (in million units)

Exhibit 4: Global IVD Products and Test Market by Category Segmentation

Exhibit 5: Global IVD Products and Test Market Sales by Category Segmentation 2012

Exhibit 6: Global IVD Products and Test Market Sales by Category Segmentation 2012-2016

Exhibit 7: Global IVD Products and Test Market Volume by Category Segmentation 2012

Exhibit 8: Global IVD Products and Test Market Volume by Category Segmentation 2016-2016

Exhibit 9: POC Test Procedure by Category Segmentation

Exhibit 10: POC Test Procedure Volume by Category Segmentation 2012

Exhibit 11: Global Procedure Volume of OTC Tests 2012-2016 (in million units)

Exhibit 12: OTC Test Procedure Volume by Category Segmentation 2012

Exhibit 13: Global OTC Test Sales 2012-2016 (in US$ million)

Exhibit 14: Global OTC Test Sales by Category Segmentation 2012

Exhibit 15: Global Procedure Volume of Glucose Tests 2012-2016 (in million units)

Exhibit 16: Global Glucose Test Sales 2012-2016 (in US$ million)

Exhibit 17: Global Procedure Volume of Pregnancy/Ovulation Tests 2012-2016 (in million units)

Exhibit 18: Global Pregnancy/Ovulation Test Sales 2012-2016 (in US$ million)

Exhibit 19: Global Procedure Volume of Other Tests 2012-2016 (in million units)

Exhibit 20: Global Other Test Sales 2012-2016 (in US$ million)

Exhibit 21: Global Procedure Volume of Professional Tests 2012-2016 (in millions units)

Exhibit 22: Professional Test Procedure Volume by Category Segmentation 2012

Exhibit 23: Global Professional Test Sales 2012-2016 (in US$ million)

Exhibit 24: Global Professional Test Sales by Category Segmentation 2012

Exhibit 25: Global Procedure Volume of Glucose Tests 2012-2016 (in million units)

Exhibit 26: Global Glucose Test Sales 2012-2016 (in US$ million)

Exhibit 27: Global Procedure Volume of Infectious Disease Tests 2012-2016 (in million units)

Exhibit 28: Global Infectious Disease Test Sales 2012-2016 (in US$ million)

Exhibit 29: Global Procedure Volume of Critical Care Tests 2012-2016 (in million units)

Exhibit 30: Global Critical Care Test Sales 2012-2016 (in US$ million)

Exhibit 31: Global Procedure Volume of Other Tests 2012-2016 (in millions)

Exhibit 32: Global Other Test Sales 2012-2016 (in US$ million)

Exhibit 33: Global Procedure Volume of POC Tests 2012-2016 (in million units)

Exhibit 34: Core Laboratory Test Procedure by Category Segmentation

Exhibit 35: Core Laboratory Test Procedure Volume by Category Segmentation 2012

Exhibit 36: Global Procedure Volume of Clinical Chemistry Test 2012-2016 (in million units)

Exhibit 37: Clinical Chemistry Test Procedure Volume by Category Segmentation 2012

Exhibit 38: Global Clinical Chemistry Test Sales 2012-2016 (in US$ million)

Exhibit 39: Global Clinical Chemistry Test Sales by Category Segmentation 2012

Exhibit 40: Global Procedure Volume of General Chemistry Test 2012-2016 (in millions units)

Exhibit 41: Global General Chemistry Test Sales 2012-2016 (in US$ million)

Exhibit 42: Global Procedure Volume of Blood Gas Analysis 2012-2016 (in million units)

Exhibit 43: Global Blood Gas Analysis Sales 2012-2016 (in US$ million)

Exhibit 44: Global Procedure Volume of Urinalysis 2012-2016 (in million units)

Exhibit 45: Global Urinalysis Sales 2012-2016 (in US$ million)

Exhibit 46: Global Procedure Volume of Immunoassay 2012-2016 (in million units)

Exhibit 47: Immunoassay Procedure Volume by Category Segmentation 2012

Exhibit 48: Global Immunoassay Sales 2012-2016 (in US$ million)

Exhibit 49: Global Immunoassay Sales by Category Segmentation 2012

Exhibit 50: Global Procedure Volume of Infectious Disease Tests 2012-2016 (in million units)

Exhibit 51: Global Infectious Disease Test Sales 2012-2016 (in US$ million)

Exhibit 52: Global Procedure Volume of Cardiac Markers 2012-2016 (in million units)

Exhibit 53: Global Cardiac Marker Sales 2012-2016 (in US$ million)

Exhibit 54: Global Procedure Volume of Tumour Markers 2012-2016 (in million units)

Exhibit 55: Global Tumour Marker Sales 2012-2016 (in US$ million)

Exhibit 56: Global Procedure Volume of Diabetes Tests 2012-2016 (in million units)

Exhibit 57: Global Diabetes Test Sales 2012-2016 (in US$ million)

Exhibit 58: Global Procedure Volume of Autoimmune Disease Tests 2012-2016 (in million units)

Exhibit 59: Global Autoimmune Disease Test Sales 2012-2016 (in US$ million)

Exhibit 60: Global Procedure Volume of Other Tests 2012-2016 (in million units)

Exhibit 61: Global Other Tests Sales 2012-2016 (in US$ million)

Exhibit 62: Global Procedure Volume of Core Laboratory Tests 2012-2016 (in millions)

Exhibit 63: Molecular Test Procedure by Category Segmentation

Exhibit 64: Molecular Test Procedure Volume by Category Segmentation 2012

Exhibit 65: Global Procedure Volume of Infectious Disease Tests 2012-2016 (in millions)

Exhibit 66: Global Infectious Disease Test Sales 2012-2016 (in US$ million)

Exhibit 67: Global Procedure Volume of Oncology Tests 2012-2016 (in millions)

Exhibit 68: Global Oncology Test Sales 2012-2016 (in US$ million)

Exhibit 69: Global Procedure Volume of Inherited Disease Tests 2012-2016 (in million units)

Exhibit 70: Global Inherited Disease Test Sales 2012-2016 (in US$ million)

Exhibit 71: Global Procedure Volume of Other Tests 2012-2016 (in million units)

Exhibit 72: Global Other Test Sales 2012-2016 (in US$ million)

Exhibit 73: Global Procedure Volume of Molecular Test 2012-2016 (in millions)

Exhibit 74: Global Procedure Volume of Haematology Test 2012-2016 (in million units)

Exhibit 75: Coagulation Test Procedure by Category Segmentation

Exhibit 76: Global Procedure Volume of Coagulation Test 2012-2016 (in millions)

Exhibit 77: Microbiology Test Procedure by Category Segmentation

Exhibit 78: Microbiology Test Procedure Volume by Category Segmentation 2012

Exhibit 79: Global Procedure Volume of Automated Panels and Reagents 2012-2016 (in millions)

Exhibit 80: Global Automated Panels and Reagents Sales 2012-2016 (in US$ million)

Exhibit 81: Global Procedure Volume of Blood Culture 2012-2016 (in million units)

Exhibit 82: Global Blood Culture Sales 2012-2016 (in US$ million)

Exhibit 83: Global Procedure Volume of Chromogenic Media Test 2012-2016 (in million units)

Exhibit 84: Global Chromogenic Media Test Sales 2012-2016 (in US$ million)

Exhibit 85: Global Procedure Volume of Manual Panels and Reagents 2012-2016 (in million units)

Exhibit 86: Global Manual Panels and Reagents Sales 2012-2016 (in US$ million)

Exhibit 87: Global Procedure Volume of Microbiology Test 2012-2016 (in millions)

Exhibit 88: Global Procedure Volume of Blood Banking Tests 2012-2016 (in million units)

Exhibit 89: Histology/Cytology Test Procedure by Category Segmentation

Exhibit 90: Histology/Cytology Test Procedure Volume by Category Segmentation 2012

Exhibit 91: Global Procedure Volume of Pap Stains 2012-2016 (in million units)

Exhibit 92: Global Pap Stains Sales 2012-2016 (in US$ million)

Exhibit 93: Global Procedure Volume of Non-pap Stains 2012-2016 (in million units)

Exhibit 94: Global Non-pap Stains Sales 2012-2016 (in US$ million)

Exhibit 95: Global Procedure Volume of Image Cytometry 2012-2016 (in million units)

Exhibit 96: Global Image Cytometry Sales 2012-2016 (in US$ million)

Exhibit 97: Global Procedure Volume of Flow Cytometry 2012-2016 (in million units)

Exhibit 98: Global Flow Cytometry Sales 2012-2016 (in US$ million)

Exhibit 99: Global Procedure Volume of IHC Tests 2012-2016 (in million units)

Exhibit 100: Global IHC Test Sales 2012-2016 (in US$ million)

Exhibit 101: Global Procedure Volume of ISH Tests 2012-2016 (in million units)

Exhibit 102: Global ISH Test Sales 2012-2016 (in US$ million)

Exhibit 103: Global Procedure Volume of CTC Tests 2012-2016 (in million units)

Exhibit 104: Global CTC Test Sales 2012-2016 (in US$ million)

Exhibit 105: Global Procedure Volume of Histology/Cytology Test 2012-2016 (in million units)

Exhibit 106: Global POC Test Sales 2012-2016 (in US$ million)

Exhibit 107: Global POC Test Sales by Category Segmentation 2012

Exhibit 108: Global Core Laboratory Test Sales 2012-2016 (in US$ million)

Exhibit 109: Global Core Laboratory Test Sales by Category Segmentation 2012

Exhibit 110: Global Molecular Test Sales 2012-2016 (in US$ million)

Exhibit 111: Global Molecular Test Sales by Category Segmentation 2012

Exhibit 112: Global Haematology Test Sales 2012-2016 (in US$ million)

Exhibit 113: Global Coagulation Test Sales 2012-2016 (in US$ million)

Exhibit 114: Global Microbiology Test Sales 2012-2016 (in US$ million)

Exhibit 115: Global Microbiology Test Sales by Category Segmentation 2012

Exhibit 116: Global Blood Banking Test Sales 2012-2016 (in US$ million)

Exhibit 117: Global Histology/Cytology Test Sales 2012-2016 (in US$ million)

Exhibit 118: Global Histology/Cytology Test Sales by Category Segmentation 2012

Exhibit 119: Global IVD Products and Test Market by Geographical Segmentation 2012

Exhibit 120: Vendor Segmentation of Global IVD Products and Test Market by Sales 2012

Exhibit 121: Vendor Segmentation of Global IVD Products and Test Market by Volume 2012

Exhibit 122: Business Segmentation of Abbott Laboratories

Exhibit 123: Business Segmentation of Becton Dickinson and Company

Exhibit 124: Business Segmentation of bioMerieux SA

Exhibit 125: Business Segmentation of Hoffmann-La Roche Ltd.

Exhibit 126: Business Segmentation of Siemens Healthcare


Enquiry Before Buy
image
Can´t read the image ? refresh here.